Showing results (1761-1770 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|May 12, 2021
Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndromeKeitaro Kanie, Genzo Iguchi, Hironori Bando, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1985
Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigsT Matsuzaki, T Yokokura, I AzumaCancer Immunology, Immunotherapy : CII|April 29, 1998
Contribution of the T cell receptor BJ gene to recognition of the P91A tumor antigen in DBA/2 miceS Suzuki, K Masuko-Hongo, T A Höger, et al.Cancer Immunology, Immunotherapy : CII|June 8, 2020
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancerQilai Long, Ai-Hong Ma, Hongyong Zhang, et al.Cancer Immunology, Immunotherapy : CII|June 12, 2020
IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinomaYujia Zheng, Yu Li, Bo Tang, et al.Cancer Immunology, Immunotherapy : CII|May 31, 2020
In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypesMorten Nielsen, Anders Krarup-Hansen, Dorrit Hovgaard, et al.Cancer Immunology, Immunotherapy : CII|May 14, 2020
The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinomaDaniëlle Krijgsman, Natasja L De Vries, Morten N Andersen, et al.Cancer Immunology, Immunotherapy : CII|September 17, 2021
Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancerHarsimar B Kaur, Thiago Vidotto, Adrianna A Mendes, et al.Cancer Immunology, Immunotherapy : CII|September 14, 2021
The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoidesOleg Kruglov, Lisa D S Johnson, Angela Minic, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1982
Interference of anti-tumor and immunosuppressive effects of cyclophosphamide in tumor-bearing rats. Analysis of factors determining resistance or susceptibility to a subsequent tumor challengeD Vidović, M Marusić, F CuloPageof 652